Dual orexin receptor antagonism with lemborexant enhances microglial clearance of β-amyloid in mice. [PDF]
Sharma A +14 more
europepmc +1 more source
Comment on "Effects of Vornorexant, a Dual Orexin Receptor Antagonist, on Bladder Function in Rats and Nocturnal Voiding Frequency in Patients With Insomnia". [PDF]
Malik MMUD, Jayaswal RP.
europepmc +1 more source
Investigation of a simple suspension method for orexin receptor antagonist tablets. [PDF]
Hada K +6 more
europepmc +1 more source
Long-term use of dual orexin receptor antagonists for the treatment of insomnia: a systematic review and meta-analysis. [PDF]
Araujo LMM +6 more
europepmc +1 more source
Effects of Vornorexant, a Dual Orexin Receptor Antagonist, on Bladder Function in Rats and Nocturnal Voiding Frequency in Patients With Insomnia. [PDF]
Hikichi H +5 more
europepmc +1 more source
Comparison of objective sleep variables in schizophrenia with comorbid insomnia treated with dual orexin receptor antagonists versus benzodiazepine receptor agonists. [PDF]
Arai Y +9 more
europepmc +1 more source
Dual orexin receptor antagonists for preventing delirium in hospitalized older adults: protocol for a randomized-trial systematic review and meta-analysis. [PDF]
He S, Zeng J, Zhang Y, Ruan X.
europepmc +1 more source
Novel 3‑Heteroaryl Pyrrolidine and Piperidine Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, namely, Narcolepsy and Hypersomnia. [PDF]
Sabnis RW.
europepmc +1 more source
Release of the neuropeptides corticotropin-releasing factor (CRF) and orexin-A in the ventral tegmental area (VTA) play an important role in stress-induced cocaine-seeking behavior.
McCormick, Peter J. +17 more
core +1 more source
Orexin receptor antagonists for major depressive disorder: perspectives from a systematic review and meta-analysis. [PDF]
Kishi T +5 more
europepmc +1 more source

